Beacon is a commercial-stage precision neurotechnology company using AI-driven EEG analytics to transform drug development, diagnostics, and real-world evidence generation for neurological and sleep disorders.

Beacon’s platform combines a clinical-grade wearable EEG headband with proprietary AI software to capture high-quality brainwave data at home. This yields FDA-cleared, quantitative sleep biomarkers and clinical insights not possible with traditional home sleep tests. By integrating hardware with machine learning analytics, Beacon has created a powerful commercial “flywheel” of clinical trial support, diagnostic services, and real-world data generation. The company is positioned as a key emerging partner for data-driven precision neurotherapeutic drug development and commercialization.